Benefits
Glucose Management Support
Cinnamon FenuMat clinically substantiated for glucose management — modest improvements in fasting glucose, postprandial glucose, HbA1c.
FenuMat® Bioavailability Enhancement
Same FenuMat fenugreek matrix as other Akay products — enhances cinnamon bioactive delivery and absorption.
Insulin Sensitivity Adjunct
Combined cinnamon + fenugreek both modestly support insulin signaling.
Metabolic Health Markers
Effects extend beyond glucose to lipid profile and metabolic syndrome markers.
Coumarin Considerations Addressed
FenuMat technology may help address coumarin concerns of cassia cinnamon by extracting selectively.
Mechanism of action
Cinnamon Insulin Sensitization
Cinnamon compounds (methylhydroxychalcone polymer/MHCP) have insulin-mimetic activity in research.
Alpha-Glucosidase Inhibition
Modest alpha-glucosidase inhibition slows carbohydrate digestion.
Fenugreek Glucose Effects
Fenugreek's separate glucose effects (slowed gastric emptying, fiber effects) provide complementary mechanism.
FenuMat® Bioavailability
Fenugreek galactomannan matrix enhances bioactive delivery.
Clinical trials
Akay Bioactives clinical evaluation of Cinnamon FenuMat for glucose applications.
Adults with glucose management concerns.
Glucose marker improvements.
About this ingredient
CINNAMON FENUMAT® is a PATENTED CINNAMON BARK EXTRACT formulated with FENUMAT® technology developed by AKAY BIOACTIVES. CINNAMON BACKGROUND: bark of Cinnamomum trees; CASSIA cinnamon contains coumarin (potentially hepatotoxic at high doses); CEYLON cinnamon naturally lower in coumarin; both have glucose-modulating activity.
KEY DISTINCTIONS: (1) FENUMAT® technology for bioavailability; (2) Combined cinnamon + fenugreek glucose effects; (3) Akay's specific glucose-focused standardization; (4) Possible coumarin profile improvement.
EVIDENCE-BASED USES: (1) Glucose management; (2) Insulin sensitivity adjunct; (3) Metabolic health markers; (4) Bioavailable cinnamon delivery.
CRITICAL CAUTIONS: (1) DIABETES MEDICATIONS — combined cinnamon + fenugreek hypoglycemic effects; monitor closely; (2) PREGNANCY — fenugreek contraindicated; AVOID; (3) FENUGREEK ALLERGY — same considerations; (4) CINNAMON HEPATOTOXICITY — coumarin in cassia cinnamon can cause hepatotoxicity at high chronic doses; FenuMat extraction may modify coumarin profile; verify product specifications; (5) DOSE — per Akay specification; (6) DURATION — metabolic effects build over weeks/months; (7) CINNAMON FENUMAT vs CINNULIN (Verdure) vs CEYLON CINNAMON — multiple cinnamon options; different processing approaches; (8) FOR COMPREHENSIVE METABOLIC HEALTH — diet, exercise, weight foundational; supplements adjunct; (9) BRAND VERIFICATION — Cinnamon FenuMat® is Akay Bioactives trademark.